Sanctuary Advisors
TGTX icon

Sanctuary Advisors’s TG Therapeutics TGTX Stock Holding History

Sanctuary Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$201K Buy
+3,602
New +$195K ﹤0.01% 2757
2026
Q2 		– Sell
-7,697
Closed -$256K – 2928
2026
Q1 		$256K Buy
+7,697
New +$229K ﹤0.01% 2193

Other funds holding TGTX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Sanctuary Advisors's TGTX Position: Q3 2026 in Review

Sanctuary Advisors opened a new position in TG Therapeutics (TGTX) in Q3 2026: 3,602 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #2757 among its holdings. This is a return to the name: Sanctuary Advisors previously reported a position in TGTX as recently as Q1 2026.

Sanctuary Advisors first reported a position in TGTX in Q1 2026 and has held it in 2 quarters since. The position peaked at $256K in Q1 2026. 361 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Sanctuary Advisors held 3,602 shares of TG Therapeutics worth $201K as of Q3 2026.
  • TG Therapeutics was a new Sanctuary Advisors position in Q3 2026.
  • TG Therapeutics made up ﹤0.01% of Sanctuary Advisors's portfolio in Q3 2026, its #2757 holding.
  • Sanctuary Advisors first reported a position in TG Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Sanctuary Advisors's TG Therapeutics position peaked at $256K in Q1 2026.
  • 361 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Sanctuary Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.